Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 02:39PM ET
2.34
Dollar change
+0.15
Percentage change
6.85
%
IndexRUT P/E- EPS (ttm)-0.79 Insider Own2.73% Shs Outstand244.92M Perf Week-2.90%
Market Cap573.14M Forward P/E- EPS next Y-0.66 Insider Trans19.69% Shs Float238.24M Perf Month-10.34%
Income-175.61M PEG- EPS next Q-0.20 Inst Own74.32% Short Float8.96% Perf Quarter60.27%
Sales1.21M P/S473.67 EPS this Y10.13% Inst Trans18.05% Short Ratio4.45 Perf Half Y93.39%
Book/sh0.38 P/B6.16 EPS next Y7.51% ROA-82.89% Short Interest21.35M Perf Year0.86%
Cash/sh0.69 P/C3.37 EPS next 5Y- ROE-167.06% 52W Range0.92 - 3.79 Perf YTD52.94%
Dividend Est.- P/FCF- EPS past 5Y6.80% ROI-88.74% 52W High-38.24% Beta1.26
Dividend TTM- Quick Ratio5.58 Sales past 5Y186.21% Gross Margin46.97% 52W Low154.35% ATR (14)0.25
Dividend Ex-Date- Current Ratio5.60 EPS Y/Y TTM-28.28% Oper. Margin-14253.11% RSI (14)50.00 Volatility10.73% 9.88%
Employees285 Debt/Eq1.14 Sales Y/Y TTM766.91% Profit Margin-14573.20% Recom2.33 Target Price6.25
Option/ShortYes / Yes LT Debt/Eq1.13 EPS Q/Q-21.91% Payout- Rel Volume1.46 Prev Close2.19
Sales Surprise-43.88% EPS Surprise7.92% Sales Q/Q2407.14% EarningsMar 11 BMO Avg Volume4.79M Price2.34
SMA20-0.83% SMA502.72% SMA20034.78% Trades Volume5,624,014 Change6.85%
Date Action Analyst Rating Change Price Target Change
Mar-07-23Initiated Jefferies Hold $3
Aug-12-22Initiated Piper Sandler Overweight $10
Jan-29-21Upgrade JP Morgan Underweight → Neutral $7
Jan-29-21Downgrade Wedbush Outperform → Neutral $2 → $8
Dec-08-20Upgrade Citigroup Neutral → Buy
Nov-18-20Upgrade Gabelli & Co Hold → Buy
Dec-11-19Downgrade Gabelli & Co Buy → Hold
Nov-08-19Downgrade Citigroup Buy → Neutral $3 → $4
Sep-11-19Upgrade Gabelli & Co Hold → Buy $3
Jul-29-19Downgrade Stifel Buy → Hold $10 → $4
Mar-25-24 09:20AM
Mar-13-24 12:45PM
Mar-12-24 08:00AM
Mar-11-24 08:25AM
07:34AM
07:15AM Loading…
07:15AM
07:05AM
07:00AM
Feb-29-24 10:00AM
Feb-22-24 12:58PM
Jan-31-24 05:06AM
Jan-23-24 05:21AM
Jan-08-24 07:00AM
Dec-26-23 05:06AM
Dec-21-23 04:15PM
07:30AM Loading…
Nov-30-23 07:30AM
Nov-22-23 07:30AM
Nov-15-23 01:03AM
Nov-12-23 02:10PM
Nov-10-23 04:01PM
10:53AM
Nov-08-23 09:45PM
07:19AM
07:00AM
Nov-03-23 09:00AM
Nov-02-23 09:00AM
Nov-01-23 09:00AM
Oct-31-23 04:01PM
Oct-30-23 04:01PM
Oct-25-23 08:45AM
04:01PM Loading…
Oct-17-23 04:01PM
01:35PM
Oct-13-23 11:38AM
Oct-11-23 11:13AM
09:00AM
Oct-10-23 11:25AM
09:44AM
03:33AM
Oct-09-23 04:01PM
08:00AM
Sep-28-23 09:00AM
Sep-26-23 09:00AM
Sep-20-23 12:28PM
Sep-14-23 09:40PM
Sep-07-23 04:30PM
09:00AM
Aug-21-23 09:00AM
Aug-17-23 09:56AM
Aug-08-23 09:00AM
Aug-04-23 09:12AM
Aug-03-23 05:15PM
04:10PM
04:01PM
Jul-28-23 04:01PM
08:00AM
Jun-30-23 06:52AM
Jun-27-23 06:46AM
Jun-23-23 08:45PM
09:24AM
Jun-20-23 08:00AM
Jun-15-23 05:00PM
Jun-06-23 04:01PM
Jun-05-23 04:01PM
Jun-04-23 07:00AM
Jun-02-23 09:21AM
Jun-01-23 11:35AM
08:00AM
May-31-23 04:01PM
May-26-23 04:25PM
04:08PM
04:05PM
May-22-23 07:33AM
May-11-23 06:50AM
May-10-23 04:30PM
May-04-23 10:05AM
May-03-23 11:45AM
May-02-23 04:00PM
Apr-28-23 04:00PM
Apr-22-23 08:15AM
Apr-21-23 09:00AM
Apr-17-23 04:00PM
Mar-06-23 06:00AM
Mar-04-23 12:00PM
10:00AM
Mar-03-23 07:07AM
Mar-02-23 04:00PM
Feb-28-23 05:00PM
Feb-20-23 08:00AM
Feb-01-23 07:56AM
Jan-06-23 04:05PM
Dec-29-22 06:52PM
Dec-22-22 09:22AM
Dec-21-22 04:30PM
Nov-28-22 08:00AM
Nov-15-22 10:00AM
Nov-14-22 04:03PM
Nov-12-22 07:28AM
Nov-11-22 08:58AM
Nov-09-22 04:01PM
Nov-08-22 08:58AM
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COATS LONNELChief Executive OfficerNov 16 '23Buy1.0590,00094,797914,359Nov 17 04:55 PM
COATS LONNELChief Executive OfficerNov 10 '23Buy1.0110,00010,100824,359Nov 13 05:31 PM
DEBBANE RAYMONDDirectorOct 12 '23Buy1.03148,820153,8051,340,847Oct 12 04:01 PM
DEBBANE RAYMONDDirectorOct 11 '23Buy1.08342,874370,7841,192,027Oct 12 04:01 PM
DEBBANE RAYMONDDirectorOct 10 '23Buy1.14508,306579,367849,153Oct 12 04:01 PM
WADE JEFFREY LPresident and CFOSep 14 '23Buy1.3810,00013,800264,341Sep 14 05:05 PM
McDermott WendyVP, Human ResourcesAug 04 '23Buy1.846,00011,04028,478Aug 07 04:13 PM
COATS LONNELChief Executive OfficerJun 29 '23Buy2.1610,00021,600814,359Jun 29 04:13 PM
COATS LONNELChief Executive OfficerJun 26 '23Buy2.1810,00021,792804,359Jun 26 04:04 PM
COATS LONNELChief Executive OfficerJun 23 '23Buy2.5010,00024,950794,359Jun 26 04:04 PM
McDermott WendyVP, Human ResourcesJun 23 '23Buy2.4310,00024,30022,478Jun 27 04:22 PM
COATS LONNELChief Executive OfficerJun 22 '23Buy2.3140,00092,400784,359Jun 22 04:01 PM
WADE JEFFREY LPresident and CFOJun 20 '23Buy2.3312,00028,000254,341Jun 20 04:10 PM
Artal International S.C.A.DirectorJun 05 '23Buy2.6027,775,05072,215,13078,634,381Jun 05 04:46 PM
Swain Judith LDirectorMay 21 '23Option Exercise0.009,302040,332May 22 04:07 PM
NIES ALAN SDirectorMay 21 '23Option Exercise0.009,302041,046May 22 04:05 PM
DEBBANE RAYMONDDirectorMay 21 '23Option Exercise0.009,3020340,847May 22 04:03 PM
LEFKOWITZ ROBERT J MDDirectorMay 21 '23Option Exercise0.009,302040,332May 22 04:04 PM
Palantoni FrankDirectorMay 21 '23Option Exercise0.009,302040,332May 22 04:06 PM
SOBECKI CHRISTOPHER JDirectorMay 21 '23Option Exercise0.009,3020159,023May 22 04:06 PM
Amouyal PhilippeDirectorMay 21 '23Option Exercise0.009,302040,332May 22 04:01 PM
BARKER SAM LDirectorMay 21 '23Option Exercise0.009,302079,617May 22 04:02 PM